This site is intended for healthcare professionals only

The Diabetic
Foot Journal

Issue:

Share this article

Diabetes foot screening: what is needed to do this in a real world primary care setting?

Adrian H Heald, Gabriela Cortes, Mark Lunt, Martin Rutter, Simon G Anderson, Mike Edmonds, Edward Jude, Andrew Boulton, George Dunn
Foot ulceration is the most common complication in diabetes with a lifetime risk of 25% (Boulton et al, 2008). The condition portends significant excess morbidity and mortality in individuals with diabetes already facing reduced life expectancy and unfavourable prognosis. The authors’ aim was to determine how data collected in the course of diabetes reviews of patients in UK primary care can inform a risk model to predict de novo foot ulcer presentation. The authors found that people with foot ulcers were significantly older than those without, and had higher HbA1c, higher serum creatinine and greater social disadvantage. Absence of monofilament sensation was more common in people with a foot ulcer, as was absence of foot pulses. However, more accurate determination of foot deformity and pedal circulation in the UK GP setting may improve the predictive value of a future risk model for use in primary care.

Foot ulceration is a major complication of type 1 and type 2 diabetes. The lifetime risk of foot ulceration in people with diabetes is 25% (Boulton et al, 2008). The authors aimed to determine how data routinely collected can inform a risk model to predict de novo foot ulcer presentation in the primary care setting. Data were available on 15,926 individuals without foot ulcers and 1,127 individuals with new foot ulcers over 12-year follow-up in UK primary care. The authors examined known risk factors and added putative risk factors in the logistic model.

People with foot ulcers were 4.2 years older than those without and had higher HbA1c, creatinine and Townsend score indicative of higher social disadvantage. Absence of monofilament sensation was more common in people with foot ulcers, likewise was absence of foot pulses.

There was no difference between people with or without foot ulcers in smoking status, gender, history of stroke or foot deformity, although foot deformity was reportedly extremely rare (0.4% in people with foot ulcers, 0.6% in people without foot ulcers). Combining risk factors in a single logistic regression model gave modest predictive power with an area under the receiver operating characteristic (ROC) curve of 0.65. The prevalence of ulceration in the bottom decile of risk was 1.8% and in the top decile 13.4% (compared to a overall prevalence of 6.5%). Thus the presence of all six risk factors gave a relative risk of 7.4 for development of a foot ulcer over 12 years.

The authors have made some progress towards defining a variable set that can be used to create a foot ulcer prediction model. However, more accurate determination of foot deformity/pedal circulation in primary care should improve the predictive value of such a future risk model, as will identification of additional risk variables, such as ability to bend down to reach the foot.

What is already known about this subject?
Foot ulceration presages significant excess morbidity and mortality in individuals with diabetes already facing reduced life expectancy, as well as unfavourable prognosis.

What is the key question?
The authors’ aim was to determine how data collected during the course of diabetes reviews of patients in UK primary care can inform a risk model to predict de novo foot ulcer presentation.

What are the new findings?
People with foot ulcers were significantly older than those without and had higher HbA1c, raised creatinine and greater social disadvantage. Absence of monofilament was more common in people with a foot ulcer, as was absence of foot pulses. More accurate determination of foot deformity and pedal circulation in primary care foot screening may improve the predictive value of a future risk model for use in primary care.

Background
As mentioned previously, foot ulceration is the most common complication in diabetes with a lifetime risk of 25% (Boulton et al, 2008). The condition portends significant excess morbidity and mortality in people with diabetes already facing reduced life expectancy (Boulton et al, 2005; 2008; Ghanassia et al, 2008). Established aetiological risk factors for foot ulceration in diabetes are sub-optimally controlled diabetes, peripheral neuropathy, peripheral vascular disease, foot deformity and previous foot ulceration.

The incidence of foot ulcers is around 2.2% per annum in the UK with an average 7,000 people with diabetes undergoing leg, foot or toe amputation each year (Heald et al, 2018). The financial burden is very significant in terms of healthcare costs and long-term consequences. The annual NHS expenditure on diabetes foot-related care is estimated to be  at least £639mn–£662mn (Diabetes UK, 2014). Consequently, better precision in understanding the risk calculus in relation to development of diabetic foot ulcers and the likelihood of death in such individuals will result in reduced health services costs with potential cost savings over the longer term.

The NICE guideline NG19, which was published in August 2015 (NICE, 2015) on the management of diabetes foot problems indicated there is still no good evidence to support any particular schedule for monitoring and foot examination in relation to prediction of risk of diabetes foot ulceration. This study aimed to provide an evidence base to address this gap.

The recently published PODUS study (Crawford et al, 2015) has shown that risk assessment procedures for individuals recommended by NICE can be simplified. This was discussed by Monteiro-Soares et al (2017), who concluded that although all the existing classifications are valid to be applied in a high-risk clinical context and have a very high capacity to categorise as low risk those individuals with diabetes who will not develop a foot ulcer, further research is needed in the primary care setting in this area.

A validated risk assessment tool that can be applied in primary care has the potential to lead to improvements in patient care and in the cost effectiveness of screening for diabetes foot complications. There is already in place in Scotland a standardised online foot screening tool called SCI-Diabetes, which collects all known risk factors and automatically calculates risk. The training is available at www.diabetesframe.org website.

The authors’ aim was to determine how data collected in the course of diabetes reviews of people in UK primary care can inform what additional data need to be collected, in order to enable a model for foot ulcer risk prediction to be applicable in the primary care setting. Prior foot ulceration was not included as people with a history of this are already closely monitored and are at greatly elevated risk of further ulceration (Anderson et al, 2018).

Methods
Pseudo-anonymised electronic health records were examined in a retrospective cohort of all men and women aged 16–89 years, attending 46 general practices (GPs) in Central/Eastern Cheshire and Derbyshire, UK. The total population of the geographical area studied is 475,000 people. The area is a mixed urban and rural environment with a wide range of socioeconomic situation from significantly disadvantaged urban areas to highly affluent suburbs and rural areas (Figure 1). The prevalence of significant social disadvantage (based on multiple measures) was 23% (Townsend Score) (Townsend, 1988).

Data were available on 15,926 individuals without foot ulcers and 1,127 individuals with new foot ulcers over 12-year follow-up. The choice of follow-up period was such as to maximise the duration of follow-up of the individuals to enable a significant number of foot ulcer cases to be identified in relation to the modelling to be conducted.
The authors examined known risk factors and added putative risk factors in the logistic model: age, HbA1c, creatinine, Townsend score, smoking status, gender, absence of monofilament response, absence of foot pulse and presence of foot deformity.

Individuals were eligible for inclusion if they had a diagnosis of diabetes prior to cohort entry at January 1, 2004 to allow long-term follow-up. They had no prior history of foot ulceration. Data search was performed through the centralised data facility afforded by Egton Medical Information Systems (EMIS®), a commercial organisation that provides health information for all but one GP practice in Cheshire. Search terms for included all relevant Read codes (NHS Digital, 2018) for diabetes and foot ulceration together with relevant Read codes for the variables included in the analysis. ‘Missingness’ in terms of any data point was defined as the variable not being available in the period between January 1, 2004 and December 31, 2005. For the final model, only individuals with all variables available were included. The data are exported from the EMIS database in a CSV format. Data cleaning was performed in using Stata 13 (Statacorp). The predictors used in developing the multivariable prediction model were those routinely recorded in the primary care setting.

Co-author Heald conducted the search with the assistance of an experienced collaborator in search methodology using Read codes from EMIS. Permission for this study was sought through the local information governance committees.

Statistical analysis
Exploratory data analysis was performed using Stata 13. Analysis included comparison of risk factors between people with or without foot ulcers and for prediction of risk, stepwise selection of predictors without pre-categorising the continuous predictors. Patient-related data are quoted as arithmetic means with standard deviation. Those individuals with a history of foot ulceration were excluded from logistic risk modelling. Goodness of fit was tested using the Hosmer-Lemeshow test (HL test).

Results
Foot ulcers occurred in 1,127 of the 17,053 individuals (7%), after a median time of 5.0 years (IQR 2.6, 8.1 years). Those who developed foot ulcers were significantly older at baseline (mean age 77.9±(sd) 14.1 versus 73.8±16.9 years) than those without, and had higher HbA1c% (mean 7.9±1.9 versus 7.5±1.7)/HbA1C mmol/mol (63±21/59±19) (P<0.0001), creatinine (μmol/L) (100±46 versus 93.0±39) (P=0.0001) and social disadvantage a measured by Townsend Score (a higher score relates to greater social disadvantage) (-0.72±2.84 versus -1.14±2.70) (P=0.02). Absence of monofilament sensation was significantly more common in people with a foot ulcer (left foot 21.5%; right foot 26.2% versus people without a foot ulcer (left foot 16.5%; right foot 18.8%) (P<0.0001) as was absence of one or more foot pulses (P=0.017) (Figure 2).

There was no difference between people with or without foot ulcers in smoking status, gender, history of stroke or foot deformity, although foot deformity was extremely rare (0.4% in people with foot ulcers, 0.6% in people without foot ulcers).

The best prediction was obtained by stepwise selection of predictors in a logistic regression model without pre-categorising the continuous predictors. In this case, the statistically significant predictors were:  HbA1c, age, monofilament sensation absent, creatinine and history of stroke. This model, gave modest predictive power, with an area under the ROC curve of 0.65 (95% CI 0.62–0.67). The absolute risk of ulceration in the bottom decile of risk was 1.8% and in the top decile 13.4%. Thus, the presence of all six risk factors gave a relative risk of 7.4 for development of a foot ulcer over 12 years. The final model where p = probability of a foot ulcer developing was: Log(p/(1-p))-6.398+{0.217×HbA1c} + {0.023×Age}+{0.380×[Monofilament sensation absent]}+{0.003×creatinine}{-0.505×[history of stroke]}.

Discussion
Some progress has been made in defining the data that need to be collected to develop a viable model for foot ulcer prediction. More accurate determination of foot deformity and pedal circulation in the UK GP setting may improve the positive predictive value of the model. Previous studies suggest that these risk factors may have strong predictive value. It is clear that vascular dysfunction must be severe, in order to predispose to ulcer formation. However, diminished sensation appears to be implicit in ulcer formation. An insensate foot means that trauma, even minor is not sensed (Boulton et al, 2008; Ghanassia et al; 2008).

We have demonstrated that age over 55 years, serum creatinine over 150μmol/L, HbA1C over 9.5% (80 mmol/mol), social disadvantage, absent monofilament sensation and absent foot pulse are relevant to evaluation of the risk of foot ulceration. Other factors, including smoking status, gender and foot deformity were not associated with the development of a foot ulcer. This compares with the Seattle study findings (Boyko et al, 2006), which identified a similar group of risk factors, including impaired vision, tinea pedis and onychomycosis in US veterans. However, their model also included previous foot ulcer and prior amputation both of which are associated with a very significantly elevated risk of future ulceration. In the PODUS meta-analysis of 16 cohort studies (Crawford et al, 2015) from more than 16,000 people, female sex was protective when the data in the PODUS dataset were analysed but this effect was not maintained in the validation analysis using the external cohort dataset.

Readily available clinical information has substantial predictive power for the development of diabetic foot ulcer (Crawford et al, 2015; Monteiro-Soares et al, 2017; Anderson et al, 2018) and may help in accurately targeting persons at high risk of this outcome for preventive interventions. As stated above, Boyko et al in 2006 found HbA1C, impaired vision, prior foot ulcer, prior amputation monofilament insensitivity, tinea pedis and onychomycosis to be predictive factors for future foot ulceration. In a systematic review of individual patient data, (Crawford et al, 2015) (PODUS study) it was determined that the 10g monofilament test most consistently identifies those people with diabetes who are at risk of foot ulceration, regardless of if they are at low, moderate or high risk of ulceration. An inability to feel a 10-g monofilament was at least as predictive as the groups of tests currently recommended in national and international clinical guidelines.

The lack of significant contribution from vascular supply to the likelihood of foot ulceration is relevant to healing processes but perfusion has to be severely reduced, to compromise the integrity of the soft tissues and predispose to ulceration. Furthermore, determination of absence of foot pulses may be less accurate than determination of loss of sensation using a monofilament. The difference in laterality of the foot in relation to the risk prediction model is intriguing in our results and may simply relate to the low frequency of pulse absence in people with foot ulcers. It may also be the case that in the primary care setting there is sometimes inaccurate evaluation of foot pulses, which could potentially be improved through use of arterial doppler studies. Irrespective of this, the modelling indicates that some clear risk factors that predict future foot ulceration can be identified.

Additional risk variables will need to be identified to improve prediction to clinically useful levels to predict foot ulcers. The authors suggest that inability to see or reach the foot be added as a risk factor, as should accurate recording of foot deformity. Type of footwear, including new shoes, is another potential risk factor that will be included in a future model.

In relation to foot deformity, which was under reported, the authors propose that training of practice nurses with regard to the accurate recording of minor, but still clinically significant, foot deformity is conducted by the local podiatry team.
There were limitations to the dataset that was collected. However, this does reflect the way that data that is routinely collected in UK primary care at diabetes reviews. There are caveats with regards to the drawing of conclusions from data routinely collected data (Bohensky et al, 2010; Hemkens et al, 2016). The point of the paper was to describe how the most could be made of the data collected and improve its quality.

In conclusion, the purpose of the study was to determine what variable may go into a systematic study to look at the determinants of foot ulceration in GP practices. Derivation of a clinically applicable predictive algorithm would come out of the data generated by such a study.

The findings of this study will inform what additional data should be collected in primary care to enable model development for prediction of future foot ulceration. More accurate determination of foot deformity and pedal circulation in the primary care setting should improve the positive and negative predictive value of any future model, as will identification of additional risk variables. The development of a validated and standardised system (as already present in Scotland), which collects all known risk factors and automatically calculates risk, is something that would be very valuable to rollout for all people involved in foot screening in England. Training has been extended on the www.diabetesframe.org website to be suitable in England.

The CPD module for this article can be found here.

REFERENCES:

Anderson SG, Shoo H, Saluja S et al (2018) Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort. Diabetologia 61(4): 959–67
Bohensky MA, Jolley D, Sundararajan V et al (2010) Data linkage: a powerful research tool with potential problems. BMC Health Serv Res 10: 346
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366(9498): 1719–24
Boulton AJ, Armstrong DG, Albert SF et al (2008) Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Phys Ther 88(11): 1436–43
Boyko EJ, Ahroni JH, Cohen V et al (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care 29(6): 1202–7
Crawford F, Cezard G, Chappell FM et al (2015)  A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess 19(57): 1–210
Diabetes UK (2014) The Cost of Diabetes Report. Available at: https://bit.ly/2rBreRf (accessed 20.09.2019)
Ghanassia E, Villon L, Thuan Dit Dieudonne JF et al (2008) Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study. Diabetes Care 31: 1288–92
Heald A, Lunt M, Rutter MK et al (2018) Developing a foot ulcer risk model: what is needed to do this in a real-world primary care setting? Diabet Med doi: 10.1111/dme.13837. [Epub ahead of print]
Hemkens LG, Contopoulos-Ioannidis DG, Ioannidis JPA (2016) Routinely collected data and comparative effectiveness evidence: promises and limitations. CMAJ 188(8): E158–E164
Monteiro-Soares M, Ribas R, Pereira da Silva C et al (2017) Diabetic foot ulcer development risk classifications’ validation: A multicentre prospective cohort study. Diabetes Res Clin Pract 127: 105–14
NHS Digital (2018) Read Codes. Available at: https://bit.ly/2L65Y1j (accessed 29.08.2019)
NICE (2015) Diabetic Foot Problems: Prevention and Management. NICE guideline [NG19]. Available at: https://bit.ly/2L3jDWB (accessed 29.08.2019)
Townsend P, Phillimore P, Beattie A (1988) Health and Deprivation: Inequality and the North. London: Croom Helm

Related content
Is artificial intelligence the key to better foot self-care in diabetes?
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.